Avecho Biotechnology Limited (FRA:OEZ)

Market Cap	19.76M +54.8%
Revenue (ttm)	703.18K +9.3%
Net Income	-2.51M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,000
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0050
52-Week Range	0.0005 - 0.0065
Beta	n/a
RSI	48.07
Earnings Date	May 28, 2026

About Avecho Biotechnology

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company dev...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 15
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OEZ

Financial Performance

In 2025, Avecho Biotechnology's revenue was 1.24 million, an increase of 9.28% compared to the previous year's 1.13 million. Losses were -4.42 million, 41.5% more than in 2024.

Financial numbers in AUD